Ochsner has implemented pharmacogenomics, how patients metabolize certain drugs and warnings of possible side effects, into its EHR system so that clinicians can adjust dosages for patients and provide more individualized care, according to a March 16 release from Ochsner.
The health system is one of the first to fully integrate the process into its EHR system.
These tests are part of a pharmacogenomics program Ochsner launched in March 2022. The tests are used in the health system’s cardiology, psychiatry, cancer, rheumatology, pain management and infectious disease departments.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.